Cellebrite DI (CLBT) Other Non-Current Liabilities (2020 - 2025)

Cellebrite DI's Other Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $16.7 million for Q4 2025.

• In Q4 2025, Other Non-Current Liabilities rose 139.82% year-over-year to $16.7 million; the TTM figure through Dec 2025 stood at $16.7 million (up 139.82% YoY), while the FY2025 annual figure was $16.7 million, up 139.82% from the prior year.
• Other Non-Current Liabilities was $16.7 million for Q4 2025 at Cellebrite DI, up from $7.5 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $54.1 million in Q4 2023 to a low of $5.0 million in Q2 2023.
• Historically, Other Non-Current Liabilities has averaged $9.8 million across 5 years, with a median of $6.6 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Other Non-Current Liabilities surged 903.28% in 2023, then slumped 87.15% in 2024.
• A 5-year view of Other Non-Current Liabilities shows it stood at $9.5 million in 2021, then plunged by 43.44% to $5.4 million in 2022, then soared by 903.28% to $54.1 million in 2023, then plunged by 87.15% to $7.0 million in 2024, then surged by 139.82% to $16.7 million in 2025.
• The last three Other Non-Current Liabilities figures came in at $16.7 million (Q4 2025), $7.5 million (Q3 2025), and $6.9 million (Q2 2025), per Business Quant data.